The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
| 1 | N | Nervous system | |
| 2 | N02 | Analgesics | |
| 3 | N02B | Other analgesics and antipyretics | |
| 4 | N02BF | Gabapentinoids |
| Code | Title | |
|---|---|---|
| N02BF01 | Gabapentin | |
| N02BF02 | Pregabalin | |
| N02BF03 |
| Active Ingredient | Description | |
|---|---|---|
| Gabapentin |
Gabapentin readily enters the brain and prevents seizures in a number of animal models of epilepsy. Gabapentin binds with high affinity to the α2δ (alpha-2-delta) subunit of voltage-gated calcium channels and it is proposed that binding to the α2δ subunit may be involved in gabapentin’s anti-seizure effects in animals. |
|
| Mirogabalin |
|
|
| Pregabalin |
Pregabalin binds to an auxiliary subunit (α2-δ protein) of voltage-gated calcium channels in the central nervous system. |
| Title | Information Source | Document Type | |
|---|---|---|---|
| EPIBAL Hard capsule | Υπουργείο Υγείας (CY) | MPI, EU: SmPC | |
| GABACOR Capsule, hard | Pharmaceutical Benefits Scheme (AU) | MPI, EU: SmPC | |
| GABENIL Hard capsule | Υπουργείο Υγείας (CY) | MPI, EU: SmPC | |
| LYRICA Hard capsule | European Medicines Agency (EU) | MPI, EU: SmPC | |
| NEURONTIN Capsule / Film-coated tablet / Solution | FDA, National Drug Code (US) | MPI, US: SPL/PLR | |
| NEURONTIN Capsule, hard | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
| NUBACAP Hard gelatine capsule | Health Products Regulatory Authority (ZA) | MPI, Generic | |
| NURIKA Hard capsule | Health Products Regulatory Authority (ZA) | MPI, Generic | |
| REGADEX Hard capsule | Health Sciences Authority (SG) | MPI, Generic | |
| TIMIRIL Capsule | Health Products Regulatory Authority (ZA) | MPI, Generic |
